MC
CNMD icon

Maverick Capital’s CONMED CNMD Stock Holding History

Maverick Capital’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-745
Closed -$97K – 384
2021
Q3 		$97K Buy
+745
New +$97.5K ﹤0.01% 581
2021
Q1 		– Sell
-8,396
Closed -$940K – 732
2020
Q4 		$940K Buy
8,396
+3,945
+89% +$374K 0.02% 242
2020
Q3 		$350K Buy
+4,451
New +$363K 0.01% 447

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Maverick Capital's CNMD Position: Q4 2021 in Review

Maverick Capital sold out of CONMED (CNMD) in Q4 2021, closing a stake of 745 shares — an estimated $97K sold.

Maverick Capital first reported a position in CNMD in Q3 2020 and held it in 3 quarters. The position peaked at $940K in Q4 2020. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2021.

  • Maverick Capital reported no remaining CONMED position as of Q4 2021 after selling out during the quarter.
  • Maverick Capital sold 745 CONMED shares in Q4 2021, an estimated $97K.
  • Maverick Capital first reported a position in CONMED in Q3 2020 and held it in 3 quarters.
  • Maverick Capital's CONMED position peaked at $940K in Q4 2020.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2021.

Based on Maverick Capital's 13F filing for Q4 2021, filed 14 Feb 2022.